Sodium iopodate
- Level
- Commodity
- Parent
- 51442400
- Below
- 0
- Links · KBLI
- 10
Definition
UNSPSC 51442439This classification denotes a diagnostic reagent with the molecular formula C12H12I3N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F316LLW9WW, chemically known as 2,4,6-triiodo-3-((dimethylaminomethylene)amino)hydrocinnamic acid but more generally known as ipodate sodium, which bears U.S. National Institutes of Health Compound Identifier 5241. European Medicines Agency schedules Sodium iopodate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12441MIG. The term SODIUM IOPODATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules ipodate sodium in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sodium iopodate under HS 29252900 and SITC 51482. SMILES: CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)[O-])I)I.[Na+].
Same parent
Under 51442400 · 41Activities that produce or sell this
KBLI · 10Inherited from family 51440000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.